BioSpace News Archive

Journalists with questions about how to responsibly and proactively cover the coronavirus epidemic are invited to attend an educational panel discussion next Monday night at the National Press Club.

The Biologic Association will hold their 1 st Summit Feb. 5-8 in Carlsbad, California that will provide an interactive environment for all orthobiologics stakeholders to discover, learn, exchange and collaborate new ideas and thought processes on a variety of novel biologic therapies.

Apotex Inc. is recalling certain lots because they contain a nitrosamine impurity above the acceptable limit.

Feb. 5, 2020 17:23 UTC CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is unaware of any developments concerning the business of the Company that could account for the recent trading volatility of the Company’s common stock.

VALBIOTIS announces the signature of a global long-term strategic partnership with Nestlé Health Science for the development and commercialization of TOTUM-63, an innovative and patented combination of 5 plant extracts specifically designed to reduce the risk of developing Type 2 Diabetes on prediabetics.

Physicians seeking to improve outcomes of some of their most at-risk patients – Medicare recipients with multiple chronic conditions – are finding that improving patient engagement through remote monitoring not only benefits the patient, it also adds to their bottom line.

Tidelands Health and MUSC Health are the inaugural winners of the South Carolina Hospital Association’s Capstone Award, a recognition of hospitals and health systems in South Carolina who are leaders in pursuing excellence in delivering highly reliable care, developing a healthy workforce, and building healthy communities.

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the BIO CEO & Investor Conference on Tuesday, February 11, 2020, at 11:00 a.m. Eastern Time at the New York Marriott Marquis in New York, NY.

Trovagene, Inc. (Nasdaq: TROV), today announced that a poster featuring efficacy data from its Phase 2 study in metastatic castrate-resistant prostate cancer (mCRPC), will be presented on Thursday, February 13th, 2020 at the American Society for Clinical Oncology (ASCO) 2020 Genitourinary Cancers Symposium in San Francisco.

- Presentation scheduled for Tuesday, February 11th at 10:15 am ET